Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec;199(6):492-500.
doi: 10.1192/bjp.bp.110.090373. Epub 2011 Oct 20.

Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study

John-Paul Taylor  1 , Michael Firbank, Nicola Barnett, Sarah Pearce, Anthea Livingstone, Urs Mosimann, Janet Eyre, Ian G McKeith, John T O'Brien
Affiliations

Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study

John-Paul Taylor et al. Br J Psychiatry. 2011 Dec.

Abstract

Background: The aetiology of visual hallucinations is poorly understood in dementia with Lewy bodies. Pathological alterations in visual cortical excitability may be one contributory mechanism.

Aims: To determine visual cortical excitability in people with dementia with Lewy bodies compared with aged-matched controls and also the relationship between visual cortical excitability and visual hallucinations in dementia with Lewy bodies.

Method: Visual cortical excitability was determined by using transcranial magnetic stimulation (TMS) applied to the occiput to elicit phosphenes (transient subjective visual responses) in 21 patients with dementia with Lewy bodies and 19 age-matched controls.

Results: Phosphene parameters were similar between both groups. However, in the patients with dementia with Lewy bodies, TMS measures of visual cortical excitability correlated strongly with the severity of visual hallucinations (P = 0.005). Six patients with dementia with Lewy bodies experienced visual hallucination-like phosphenes (for example, seeing people or figures on stimulation) compared with none of the controls (P = 0.02).

Conclusions: Increased visual cortical excitability in dementia with Lewy bodies does not appear to explain visual hallucinations but it may be a marker for their severity.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest

None.

Figures

Fig. 1
Fig. 1
Boxplots showing phosphene parameters in all participants (minimum, first quartile, median, third quartile and maximum displayed). (a) Phosphene threshold boxplot – there were no significant differences between the controls and patients for phosphene threshold (P = 0.56). (b) Phosphene response rate boxplot – there were no significant differences between controls and patients for phosphene response rate (P = 0.57).
Fig. 2
Fig. 2
Stimulus response plot averaged across subgroups of controls (n = 10) and patients with dementia with Lewy bodies (n = 9) who underwent the stimulus response paradigm. The Y-axis shows response rate expressed as a percentage of responses (out of 10) at a given stimulation intensity. The x-axis shows stimulation intensity expressed as a % of stimulator output relative to phosphene threshold.
Fig. 3
Fig. 3
Scatter plots showing phosphene parameters in patients with dementia with Lewy bodies (DLB) against Neuropsychiatric Inventory (NPIhall) score ((a) and (b)). (c) and (d) show phosphene parameters in all participants against phosphene complexity scores. (a) NPI v. phosphene threshold: significant negative correlation (τ = –0.49, P = 0.005); (b) NPI v. phosphene response rate: significant positive correlation (τ = 0.61, P = 0.001). (c) Complexity score v. phosphene threshold: controls and patients showed a negative correlation with phosphene threshold (controls: τ =–0.54, P = 0.003; patients: τ =–0.67, P<0.001); (d) complexity score v. phosphene response rate: controls and patients showed positive correlation with phosphene response rate (controls: τ = 0.49, P = 0.009; patients: τ = 0.55, P = 0.002). Vertical line in (a) demarcates maximum stimulation intensity; four patients had thresholds >100%. Lines in (c) and (d) show linear fits to data (dark blue: controls; light blue: patients).
Fig. 4
Fig. 4
Histograms showing frequency distribution of (a) phosphene threshold and (b) phosphene response rate in controls and patients.
See this image and copyright information in PMC

Comment in

References

    1. Aarsland D, Ballard C, Larsen JP, McKeith I. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson’s disease with and without dementia. Int J Geriatr Psychiatry 2001; 16: 528–36 - PubMed
    1. Bostrom F, Jonsson L, Minthon L, Londos E. Patients with dementia with Lewy bodies have more impaired quality of life than patients with Alzheimer disease. Alzheimer Dis & Assoc Disord 2007; 21: 150–4 - PubMed
    1. Ricci M, Guidoni SV, Sepe-Monti M, Bomboi G, Antonini G, Blundo C, et al. Clinical findings, functional abilities and caregiver distress in the early stage of dementia with Lewy bodies (DLB) and Alzheimer’s disease (AD). Arch Gerontol Geriatr 2009; 49: e101–4 - PubMed
    1. Collerton D, Perry E, McKeith I. Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations. Behav Brain Sci 2005; 28: 737–57 - PubMed
    1. Diederich NJ, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkinson’s disease as disturbed external/internal perceptions: focused review and a new integrative model. Movement Disord 2005; 20: 130–40 - PubMed

Publication types

MeSH terms

Substances